Skip to main content
. 2022 Jun 22;22:687. doi: 10.1186/s12885-022-09763-2

Table 3.

Screening for anti-LUAD/COVID-19 drugs based on cMap

Rank cMap name Mean Number Enrichment P-value
1 Puromycin − 0.729 4 − 0.959 0
2 Emetine − 0.522 4 − 0.83 0.00151
3 Glycocholic acid − 0.506 4 − 0.815 0.00211
4 Chicago Sky Blue 6B − 0.337 4 − 0.797 0.00336
5 Nitrofural − 0.297 4 − 0.781 0.00462
6 Cephaeline − 0.36 5 − 0.758 0.00154
7 Pepstatin − 0.326 4 − 0.711 0.0141
8 Cinoxacin − 0.569 4 − 0.711 0.01414
9 4-Hydroxyphenazone − 0.356 5 − 0.702 0.00511
10 Oxymetazoline − 0.502 4 − 0.702 0.01647
11 Primidone − 0.347 4 − 0.671 0.02626
12 Lycorine − 0.34 5 − 0.669 0.00917
13 Parthenolide − 0.548 4 − 0.661 0.02998
14 Sulindac − 0.437 7 − 0.654 0.00178
15 Citalopram − 0.318 4 − 0.642 0.03929
16 N-acetylmuramic acid − 0.322 4 − 0.64 0.03995
17 Tropine − 0.357 4 − 0.639 0.04084
18 Ciclosporin − 0.29 6 − 0.594 0.01577
19 Benzamil − 0.302 6 − 0.542 0.03665